Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.

Rare copy-number variation (CNV) is an important source of risk for autism spectrum disorders (ASDs). We analyzed 2,446 ASD-affected families and confirmed an excess of genic deletions and duplications in affected versus control groups (1.41-fold, p = 1.0 × 10(-5)) and an increase in affected subjec...

Full description

Bibliographic Details
Main Authors: Pinto, D, Delaby, E, Merico, D, Barbosa, M, Merikangas, A, Klei, L, Thiruvahindrapuram, B, Xu, X, Ziman, R, Wang, Z, Vorstman, J, Thompson, A, Regan, R, Pilorge, M, Pellecchia, G, Pagnamenta, A, Oliveira, B, Marshall, C, Magalhaes, T, Lowe, J, Howe, J, Griswold, A, Gilbert, J, Duketis, E, Dombroski, B
Format: Journal article
Language:English
Published: 2014
_version_ 1797099238573735936
author Pinto, D
Delaby, E
Merico, D
Barbosa, M
Merikangas, A
Klei, L
Thiruvahindrapuram, B
Xu, X
Ziman, R
Wang, Z
Vorstman, J
Thompson, A
Regan, R
Pilorge, M
Pellecchia, G
Pagnamenta, A
Oliveira, B
Marshall, C
Magalhaes, T
Lowe, J
Howe, J
Griswold, A
Gilbert, J
Duketis, E
Dombroski, B
author_facet Pinto, D
Delaby, E
Merico, D
Barbosa, M
Merikangas, A
Klei, L
Thiruvahindrapuram, B
Xu, X
Ziman, R
Wang, Z
Vorstman, J
Thompson, A
Regan, R
Pilorge, M
Pellecchia, G
Pagnamenta, A
Oliveira, B
Marshall, C
Magalhaes, T
Lowe, J
Howe, J
Griswold, A
Gilbert, J
Duketis, E
Dombroski, B
author_sort Pinto, D
collection OXFORD
description Rare copy-number variation (CNV) is an important source of risk for autism spectrum disorders (ASDs). We analyzed 2,446 ASD-affected families and confirmed an excess of genic deletions and duplications in affected versus control groups (1.41-fold, p = 1.0 × 10(-5)) and an increase in affected subjects carrying exonic pathogenic CNVs overlapping known loci associated with dominant or X-linked ASD and intellectual disability (odds ratio = 12.62, p = 2.7 × 10(-15), ∼3% of ASD subjects). Pathogenic CNVs, often showing variable expressivity, included rare de novo and inherited events at 36 loci, implicating ASD-associated genes (CHD2, HDAC4, and GDI1) previously linked to other neurodevelopmental disorders, as well as other genes such as SETD5, MIR137, and HDAC9. Consistent with hypothesized gender-specific modulators, females with ASD were more likely to have highly penetrant CNVs (p = 0.017) and were also overrepresented among subjects with fragile X syndrome protein targets (p = 0.02). Genes affected by de novo CNVs and/or loss-of-function single-nucleotide variants converged on networks related to neuronal signaling and development, synapse function, and chromatin regulation.
first_indexed 2024-03-07T05:20:54Z
format Journal article
id oxford-uuid:dedd395b-d0e8-41f0-bb5d-560bc511596e
institution University of Oxford
language English
last_indexed 2024-03-07T05:20:54Z
publishDate 2014
record_format dspace
spelling oxford-uuid:dedd395b-d0e8-41f0-bb5d-560bc511596e2022-03-27T09:35:18ZConvergence of genes and cellular pathways dysregulated in autism spectrum disorders.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dedd395b-d0e8-41f0-bb5d-560bc511596eEnglishSymplectic Elements at Oxford2014Pinto, DDelaby, EMerico, DBarbosa, MMerikangas, AKlei, LThiruvahindrapuram, BXu, XZiman, RWang, ZVorstman, JThompson, ARegan, RPilorge, MPellecchia, GPagnamenta, AOliveira, BMarshall, CMagalhaes, TLowe, JHowe, JGriswold, AGilbert, JDuketis, EDombroski, BRare copy-number variation (CNV) is an important source of risk for autism spectrum disorders (ASDs). We analyzed 2,446 ASD-affected families and confirmed an excess of genic deletions and duplications in affected versus control groups (1.41-fold, p = 1.0 × 10(-5)) and an increase in affected subjects carrying exonic pathogenic CNVs overlapping known loci associated with dominant or X-linked ASD and intellectual disability (odds ratio = 12.62, p = 2.7 × 10(-15), ∼3% of ASD subjects). Pathogenic CNVs, often showing variable expressivity, included rare de novo and inherited events at 36 loci, implicating ASD-associated genes (CHD2, HDAC4, and GDI1) previously linked to other neurodevelopmental disorders, as well as other genes such as SETD5, MIR137, and HDAC9. Consistent with hypothesized gender-specific modulators, females with ASD were more likely to have highly penetrant CNVs (p = 0.017) and were also overrepresented among subjects with fragile X syndrome protein targets (p = 0.02). Genes affected by de novo CNVs and/or loss-of-function single-nucleotide variants converged on networks related to neuronal signaling and development, synapse function, and chromatin regulation.
spellingShingle Pinto, D
Delaby, E
Merico, D
Barbosa, M
Merikangas, A
Klei, L
Thiruvahindrapuram, B
Xu, X
Ziman, R
Wang, Z
Vorstman, J
Thompson, A
Regan, R
Pilorge, M
Pellecchia, G
Pagnamenta, A
Oliveira, B
Marshall, C
Magalhaes, T
Lowe, J
Howe, J
Griswold, A
Gilbert, J
Duketis, E
Dombroski, B
Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.
title Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.
title_full Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.
title_fullStr Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.
title_full_unstemmed Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.
title_short Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.
title_sort convergence of genes and cellular pathways dysregulated in autism spectrum disorders
work_keys_str_mv AT pintod convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT delabye convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT mericod convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT barbosam convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT merikangasa convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT kleil convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT thiruvahindrapuramb convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT xux convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT zimanr convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT wangz convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT vorstmanj convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT thompsona convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT reganr convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT pilorgem convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT pellecchiag convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT pagnamentaa convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT oliveirab convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT marshallc convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT magalhaest convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT lowej convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT howej convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT griswolda convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT gilbertj convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT duketise convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders
AT dombroskib convergenceofgenesandcellularpathwaysdysregulatedinautismspectrumdisorders